Inside Therapeutics x Microfluidics from IDEX MPT: Bringing TAMARA to North America

Resources on Nanoparticle formulation

Starting May 2025 – Inside Therapeutics teams up with Microfluidics IDEX for the distribution of TAMARA in north america (USA & Canada)

A new milestone in TAMARA’s expansion achieved 

At Inside Therapeutics, we’re excited to officially announce our partnership with Microfluidics from IDEX MPT as our exclusive distributor for the TAMARA nanoparticle formulation system in the USA and Canada. 

This collaboration marks a major milestone in TAMARA’s global expansion. Following a successful across Europe – with strong adoption by academic labs, biotech companies, including installations in world-renowned institutions— we are now thrilled to bring TAMARA to North America alongside a partner as established and experienced as IDEX. 
 
With decades of experience in nanoparticle processing, the team at Microfluidics brings the expertise in top-down formulation through their trusted Microfluidizer® Technology. In contrast, TAMARA brings a bottom-up, microfluidic chip-based approach, specifically optimized for early-stage R&D and screening. Together, our technologies now span the full spectrum of nanoparticle development—from the very first microliters in discovery to full-scale production—offering unmatched versatility to researchers worldwide. 

Why Tamara ?

TAMARA is a fully integrated, plug-and-play microfluidic system that simplifies and accelerates the development of LNPs and other nanoparticles. It supports volumes ranging from as low as 200 µL up to 30 mL, enabling a smooth and scalable transition from screening to in vivo studies—all within the same system. 

Its innovative design includes: 

  • Recyclable dual-design microfluidic chips (baffle and herringbone mixers) 
  • Precise, independent control of formulation parameters (TFR, FRR) 
  • A zero-waste formulation design that eliminates head and tail losses 
  • Built-in cleaning protocols for easy reuse and faster workflows 

Whether you’re working on RNA LNPs, liposomes, peptide nanoparticles, polymeric nanocarriers, or the next generation of delivery systems, TAMARA is built to accelerate innovation—with a user-friendly interface designed for reproducibility and rapid iteration. 

North America: We’re Just Getting Started

By partnering with the team at Microfluidics, we’re not only expanding TAMARA’s reach across North America—we’re also giving researchers access to a team with unparalleled formulation expertise and robust technical support. From product selection and hands-on training to long-term maintenance and service, our collaboration ensures that scientists receive the guidance, tools, and confidence they need to bring novel therapies to life. 

A Shared Vision for Innovation

Anna Wynn

Anna Wynn

“We are thrilled to be working with the team at Inside Therapeutics and bring TAMARA to our key markets. Our commitment to helping customers solve critical problems in the biopharma sector is enriched by adding this groundbreaking R&D solution to our current portfolio. Together, we are poised to make a significant impact as we partner with our customers to bring innovative therapies to our communities.” 

At Inside Therapeutics, we couldn’t agree more. TAMARA was built to simplify and accelerate early-stage formulation, and it has already proven its value in the field. We’re now excited to support even more breakthroughs by making it widely accessible across the U.S. and Canada. 

Ready to explore TAMARA? 
To learn more about TAMARA, request a demo, or explore rental/test options, connect with the Microfluidics, IDEX MPT team or reach out to us directly. 

Let’s shape the future of nanoparticle formulation—together !

Looking to get started or improve your LNP formulation screening?

Reach out to us to discover how we can help!

    News

    Latest News and Updates from Inside Therapeutics
    Stay informed with the latest news, insights, and milestones from Inside Therapeutics.

    See all news